Pereira Philippe L, Vogl Thomas J, Helmberger Thomas
Zentrum für Radiologie, Minimal-invasive Therapie und Nuklearmedizin, SLK-Kliniken GmbH, Am Gesundbrunnen 20-26, 74078, Heilbronn, Deutschland.
Institut für Diagnostische und Interventionelle Radiologie, Universitätsklinikum Frankfurt, Johann Wolfgang Goethe Universität, Frankfurt am Main, Deutschland.
Radiologe. 2022 Mar;62(3):253-262. doi: 10.1007/s00117-022-00968-x. Epub 2022 Feb 18.
The updated German S3 guideline "Diagnostics and therapy of hepatocellular carcinoma and biliary carcinomas" covers two tumor entities. The original guideline published in 2013 focusing only on the diagnosis and therapy of hepatocellular carcinoma (HCC) has been expanded to include intrahepatic cholangiocarcinoma. These guidelines were developed within the framework of the guideline program on oncology of the Scientific Medical Society e. V. (AWMF), the German Cancer Society (DKG) and German Cancer Aid Society (DKG) under the auspices of the German Society for Digestive and Metabolic Diseases (DGVS). In addition to updated recommendations regarding histopathology, radiological diagnostics and treatments, the main innovations of the revised guidelines on HCC include a complete revision of the section on the systemic therapeutic approach in advanced stages of the disease. This article presents the significance of the current recommendations for diagnostic and interventional radiology in comparison to other national and international guidelines and should serve to improve the quality of patient care through more widespread dissemination.
最新的德国S3指南《肝细胞癌和胆管癌的诊断与治疗》涵盖了两种肿瘤类型。2013年发布的原指南仅聚焦于肝细胞癌(HCC)的诊断与治疗,现已扩展至包括肝内胆管癌。这些指南是在科学医学协会(AWMF)、德国癌症协会(DKG)和德国癌症援助协会的肿瘤学指南项目框架内,由德国消化和代谢疾病协会(DGVS)主持制定的。除了关于组织病理学、放射诊断和治疗的更新建议外,修订后的HCC指南的主要创新之处包括对疾病晚期全身治疗方法部分的全面修订。本文将当前建议与其他国家和国际指南进行比较,阐述其对诊断性和介入性放射学的意义,并应通过更广泛的传播来提高患者护理质量。